Jajodia Pharmaceuticals.Ltd. Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 13-12-2024
- Paid Up Capital ₹ 1.29 M
as on 13-12-2024
- Company Age 32 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue -24.50%
(FY 2022)
- Profit -13.52%
(FY 2022)
- Ebitda 55.40%
(FY 2022)
- Net Worth 5.31%
(FY 2022)
- Total Assets 4.51%
(FY 2022)
About Jajodia Pharmaceuticals.Ltd.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.29 M, as per Ministry of Corporate Affairs (MCA) records.
Anil Murarka and Nisha Murarka serve as directors at the Company.
- CIN/LLPIN
U24232WB1992PTC056987
- Company No.
056987
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Nov 1992
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jajodia Pharmaceuticals.Ltd.?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Murarka  | Director | 04-Mar-2002 | Current |
| Nisha Murarka | Director | 23-Mar-2002 | Current |
Financial Performance of Jajodia Pharmaceuticals.Ltd..
Jajodia Pharmaceuticals Pvt.Ltd., for the financial year ended 2022, experienced significant reduction in revenue, with a 24.5% decrease. The company also saw a substantial fall in profitability, with a 13.52% decrease in profit. The company's net worth moved up by a moderate rise of 5.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jajodia Pharmaceuticals.Ltd.?
In 2019, Jajodia Pharmaceuticals.Ltd. had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Presidency Commercial Private LimitedActive 17 years 4 monthsAnil Murarka and Nisha Murarka are mutual person
- Viewpoint Vintrade Private LimitedActive 14 years 8 months
Anil Murarka and Nisha Murarka are mutual person
- Linkpoint Investment Consultants Private LimitedActive 14 years 8 months
Anil Murarka and Nisha Murarka are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jajodia Pharmaceuticals.Ltd.?
Unlock and access historical data on people associated with Jajodia Pharmaceuticals.Ltd., such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jajodia Pharmaceuticals.Ltd., offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jajodia Pharmaceuticals.Ltd.'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
